$3.695
+0.140 (+3.79%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
REVB Prediction & Forecast by Similar Chart Analysis
Alphio's REVB stock price prediction model matches the current Revelation Biosciences Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.71 (+0.39%). The 1-week path is $3.70 (+0.06%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Revelation Biosciences Inc Stock?
Revelation Biosciences Inc is currently not a strong buy due to its ongoing financial losses and recent stock performance. The current price is $3.69, which is significantly down 83.77% year-to-date and 87.31% over the past year. Although the company has a potential total addressable market of $94 billion for its product Gemini, the recent earnings report showed a GAAP EPS of -5.92, indicating continued challenges in profitability. The main risk is the company's high net loss of $59.76 million for FY 2025, which raises concerns about its financial sustainability.
REVB stock price ended at $3.69 on Friday, after rising +3.79%
Revelation Biosciences Inc (REVB) last closed at $3.6949999, gaining +3.79%. These facts feed the 1-day and 1-week REVB price prediction above.
Analyst Consensus
Revelation Biosciences Inc (REVB): 1 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Revelation Biosciences Inc (REVB) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches REVB, ranked by similarity.
Seasonality analysis for REVB
Historically the probability of a positive November return for REVB is 0.00%. January offers the highest probability of a positive month at 21.31%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for REVB
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $3.28 | $3.56 | $4.09 | -3.60% |
| Dec 2026 | $2.66 | $3.08 | $3.08 | -16.62% |
In 2026, Revelation Biosciences Inc (REVB) is projected to range from $2.66 to $4.09.
Revelation Biosciences Inc 2026 monthly forecast
In Nov 2026, Revelation Biosciences Inc is projected to average $3.56, with a low of $3.28 and high of $4.09.
In Dec 2026, Revelation Biosciences Inc is projected to average $3.08, with a low of $2.66 and high of $3.08.
Related articles
- CPI Report and the Stock Market: How to Read October 2026 Inflation Data Before the Fed DecidesOctober 2026 CPI lands Nov 10 with no year-over-year number and Fed hike odds near 80%. Learn how to read CPI, which stocks react, and how to plan for it.
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.